DeepMed Research

Peking University First Hospital (Peking Univesity First Medical School)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive

Not Applicable

Conditions: COVID-19

Interventions: Drug: Favipiravir

First Posted Date: 2020-04-03

Last Posted Date: 2020-04-24

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 210

Registration Number: NCT04333589

Locations: 🇨🇳
Ezhou Central Hospital, Wuhan, Hubei, China
🇨🇳
Jinyintan Hospital of Wuhan, Wuhan, Hubei, China
🇨🇳
Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China

and more 5 locations

Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019

Not Applicable

Conditions: COVID-19

Interventions: Drug: Favipiravir Combined With Tocilizumab
Drug: Favipiravir
Drug: Tocilizumab

First Posted Date: 2020-03-17

Last Posted Date: 2020-04-10

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 150

Registration Number: NCT04310228

Locations: 🇨🇳
Guiqiang Wang, Beijing, Beijing, China
🇨🇳
Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China
🇨🇳
Jinyintan Hospital of Wuhan, Wuhan, Hubei, China

and more 3 locations

Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery

Not Applicable

Recruiting

Conditions: Overall Survival
Lung Cancer
Dexamethasone
Surgery
Blood Pressure Management
Postoperative Complications

Interventions: Drug: Placebo
Other: Targeted blood pressure management
Drug: Dexamethasone
Other: Routine blood presure management

First Posted Date: 2019-12-24

Last Posted Date: 2022-08-09

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 1988

Registration Number: NCT04209218

Locations: 🇨🇳
Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing, Beijing, China

Dexmedetomidine and Outcomes of Elderly Admitted to ICU After Surgery

Not Applicable

Recruiting

Conditions: Surgery
Overall Survival
Elderly
Intensive Care Unit
Dexmedetomidine

Interventions: Drug: Placebo
Drug: Dexmedetomidine

First Posted Date: 2019-12-19

Last Posted Date: 2023-09-21

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 1410

Registration Number: NCT04204798

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Compare the Skin Barrier Repair Function of Two Ceramide Containing Moisturizers

Not Applicable

Conditions: CeraVe Moisturising Lotion

Interventions: Drug: Ceramides

First Posted Date: 2019-12-04

Last Posted Date: 2019-12-04

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 30

Registration Number: NCT04185025

Locations: 🇨🇳
Peking University First Hospital, Beijing, China

Penehyclidine and Postoperative Nausea and Vomiting After Bimaxillary Surgery

Completed

Conditions: Bimaxillar Surgery
Postoperative Nausea and Vomiting
Penehyclidine

Interventions: Drug: Penehyclidine hydrochloride
Other: No penehyclidine hydrochloride

First Posted Date: 2019-10-02

Last Posted Date: 2020-06-30

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 243

Registration Number: NCT04112771

Locations: 🇨🇳
Peking University Hospital of Stomatology, Beijing, Haidian, China

Intraoperative Dexmedetomidine and Long-term Outcomes in Elderly After Major Surgery

Phase 4

Completed

Conditions: Overall Survival

Interventions: Drug: Placebo
Drug: Dexmedetomidine

First Posted Date: 2019-10-01

Last Posted Date: 2022-04-20

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 619

Registration Number: NCT04111926

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Novel Equations for Estimating Lean Body Mass in Patients With Chronic Kidney Disease

Completed

Conditions: Lean Body Mass
Chronic Kidney Diseases

First Posted Date: 2019-08-30

Last Posted Date: 2019-09-10

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 300

Registration Number: NCT04074278

Locations: 🇨🇳
Renal Division and Institute of Nephrology, Peking University First Hospital, Beijing, Beijing, China

Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery

Phase 4

Recruiting

Conditions: Pancreatic Cancer
Surgery
Epidural Block
Dexamethasone
Overall Survival

Interventions: Other: Epidural block
Drug: Dexamethasone

First Posted Date: 2019-07-19

Last Posted Date: 2021-07-08

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 260

Registration Number: NCT04025840

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Preoperative Pulmonary Systolic Pressure and Outcome After Non-cardiac Surgery:Threshold Analysis

Completed

Conditions: Pulmonary Hypertension

First Posted Date: 2019-06-05

Last Posted Date: 2019-07-09

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 19000

Registration Number: NCT03974919

Locations: 🇨🇳
First hospital Peking University, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy